Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2012 | 1 |
2014 | 1 |
2015 | 1 |
2016 | 1 |
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 2 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF V600E-Mutant KRAS Wild-Type Metastatic Colorectal Cancer.
Oncologist. 2023 Mar 17;28(3):230-238. doi: 10.1093/oncolo/oyad007.
Oncologist. 2023.
PMID: 36811382
Free PMC article.
Clinical Trial.
Central venous catheters-related-thrombosis and risk factors in oncological patients: A retrospective evaluation of recent risk scores.
Taglialatela I, Mariani L, Dotti KF, Di Vico L, Pisanu MN, Facchinetti C, De Braud F, Ferrari LAM.
Taglialatela I, et al. Among authors: dotti kf.
Tumori. 2023 Aug;109(4):363-369. doi: 10.1177/03008916221111419. Epub 2022 Jul 10.
Tumori. 2023.
PMID: 35815563
Free PMC article.
Item in Clipboard
Dose-Dense Temozolomide in Patients with MGMT-Silenced Chemorefractory Colorectal Cancer.
Pietrantonio F, de Braud F, Milione M, Maggi C, Iacovelli R, Dotti KF, Perrone F, Tamborini E, Caporale M, Berenato R, Leone G, Pellegrinelli A, Bossi I, Festinese F, Federici S, Di Bartolomeo M.
Pietrantonio F, et al. Among authors: dotti kf.
Target Oncol. 2016 Jun;11(3):337-43. doi: 10.1007/s11523-015-0397-2.
Target Oncol. 2016.
PMID: 26538496
Item in Clipboard
Comparison of outcomes of central venous catheters in patients with solid and hematologic neoplasms: an Italian real-world analysis.
Corti F, Brambilla M, Manglaviti S, Di Vico L, Pisanu MN, Facchinetti C, Dotti KF, Lanocita R, Marchianò A, de Braud F, Ferrari LAM.
Corti F, et al. Among authors: dotti kf.
Tumori. 2021 Feb;107(1):17-25. doi: 10.1177/0300891620931172. Epub 2020 Jun 12.
Tumori. 2021.
PMID: 32529962
Item in Clipboard
Circulating biomarkers in advanced colorectal cancer patients randomly assigned to three bevacizumab-based regimens.
Martinetti A, Miceli R, Sottotetti E, Di Bartolomeo M, de Braud F, Gevorgyan A, Dotti KF, Bajetta E, Campiglio M, Bianchi F, Bregni G, Pietrantonio F.
Martinetti A, et al. Among authors: dotti kf.
Cancers (Basel). 2014 Aug 29;6(3):1753-68. doi: 10.3390/cancers6031753.
Cancers (Basel). 2014.
PMID: 25256831
Free PMC article.
Item in Clipboard
Hepatic colorectal cancer metastases showing a distinctive pattern of pathological response after metronomic capecitabine and bevacizumab.
Pietrantonio F, Biondani P, Pellegrinelli A, Marchianò A, Dotti KF, Buzzoni R, Di Bartolomeo M.
Pietrantonio F, et al. Among authors: dotti kf.
Med Oncol. 2012 Dec;29(4):2838-41. doi: 10.1007/s12032-011-0132-5. Epub 2012 Jan 21.
Med Oncol. 2012.
PMID: 22271433
Item in Clipboard
Capecitabine, oxaliplatin and irinotecan in combination, with bevacizumab (COI-B regimen) as first-line treatment of patients with advanced colorectal cancer. An Italian Trials of Medical Oncology phase II study.
Di Bartolomeo M, Ciarlo A, Bertolini A, Barni S, Verusio C, Aitini E, Pietrantonio F, Iacovelli R, Dotti KF, Maggi C, Perrone F, Bajetta E.
Di Bartolomeo M, et al. Among authors: dotti kf.
Eur J Cancer. 2015 Mar;51(4):473-481. doi: 10.1016/j.ejca.2014.12.020. Epub 2015 Jan 27.
Eur J Cancer. 2015.
PMID: 25637137
Clinical Trial.
Item in Clipboard
Cite
Cite